BlackRock’s Verona Pharma VRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.5M Sell
343,696
-146,836
-30% -$13.9M ﹤0.01% 2696
2025
Q1
$31.1M Buy
490,532
+100,296
+26% +$6.37M ﹤0.01% 2636
2024
Q4
$18.1M Sell
390,236
-44,502
-10% -$2.07M ﹤0.01% 3066
2024
Q3
$12.5M Buy
434,738
+4,309
+1% +$124K ﹤0.01% 3248
2024
Q2
$6.22M Buy
430,429
+48,712
+13% +$704K ﹤0.01% 3558
2024
Q1
$6.14M Buy
381,717
+17,104
+5% +$275K ﹤0.01% 3537
2023
Q4
$7.25M Buy
364,613
+28,810
+9% +$573K ﹤0.01% 3463
2023
Q3
$5.47M Sell
335,803
-32,757
-9% -$534K ﹤0.01% 3566
2023
Q2
$7.79M Buy
368,560
+21,334
+6% +$451K ﹤0.01% 3459
2023
Q1
$6.97M Buy
347,226
+1,901
+0.6% +$38.2K ﹤0.01% 3415
2022
Q4
$9.02M Buy
345,325
+345,312
+2,656,246% +$9.02M ﹤0.01% 3383
2022
Q3
$0 Hold
13
﹤0.01% 5826
2022
Q2
$0 Buy
+13
New ﹤0.01% 5864
2021
Q4
Sell
-245,594
Closed -$1.35M 5769
2021
Q3
$1.35M Sell
245,594
-4,347
-2% -$23.8K ﹤0.01% 4415
2021
Q2
$1.64M Buy
+249,941
New +$1.64M ﹤0.01% 4287